IP Library Granted Patent US 11,873,374
Granted Patent B2
US 11,873,374 · App. 16/267,849 · Granted Jan 16, 2024

Swellable and structurally homogenous hydrogels and methods of use thereof

Inventors: Ruixuan Gao (Cambridge, MA); Linyi Gao (Cambridge, MA); Chih-Chieh Yu (Cambridge, MA); Edward Stuart Boyden (Chestnut Hill, MA)
Assignee: Massachusetts Institute of Technology
C08J3/075C08F8/00C08F8/12C08F8/30C08F8/44C08F222/104C08G65/2624C08G65/32C08G81/025C08J3/246C12Q1/68C12Q1/6834C12Q1/6841C12Q1/6869G01N1/30G01N33/545C08F220/04C08F220/303C08F220/346C08F2438/01C08G2210/00C08J2300/206C08J2400/206C12Q2523/101G01N1/36G01N15/0205
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,873,374
App. No.
16/267,849
Granted
Jan 16, 2024
Kind
B2
Abstract

The invention encompasses hydrogels, monomer precursors of the hydrogels, methods for the preparation thereof, and methods of use therefor. The linking of monomers can take place using non-radical, bioorthogonal reactions such as copper-free click-chemistry.

Claims (49)

1. A hydrogel that is the product of a non-radical polymerization reaction between a monomer of Formula (A1):

and a monomer of Formula (B1):

wherein:

each n is an integer greater than or equal to 1;

each p is an integer greater than or equal to 1;

Z + is a counter cation;

X and Y 1 are each crosslinkable moieties, and

X and Y 1 covalently crosslink to end-link the monomers.

2. The hydrogel of claim 1 , wherein X is a moiety comprising a terminal azide group and Y 1 is a moiety comprising a terminal alkyne, and wherein X and Y 1 crosslink by copper-free azide-alkyne cycloaddition.

3. The hydrogel of claim 1 , wherein X and Y 1 crosslink by amine-NHS ester reaction.

4. The hydrogel of claim 1 , wherein X and Y 1 crosslink by maleimide-thiol reaction.

5. The hydrogel of claim 1 , wherein X and Y 1 crosslink by trans-cyclooctene (TCO)-tetrazine reaction.

6. The hydrogel of claim 1 , wherein the hydrogel is labelled.

7. A composite comprising a biological sample and the hydrogel of claim 1 .

8. A method of preparing the composite of claim 7 , comprising permeating the biological sample with a monomer of Formula (A1) or a monomer of Formula (A3), and a monomer of Formula (B1) to form a hydrogel by non-radical polymerization.

9. A method of microscopy comprising:

a. permeating the biological sample with a monomer of Formula (A1):

and a monomer of Formula (B1):

to form a hydrogel according to claim 1 by non-radical polymerization;

b. isotropically expanding the composite by contacting it with an aqueous solution; and

c. viewing the expanded composite using microscopy;

wherein:

each n is an integer greater than or equal to 1;

each p is an integer greater than or equal to 1;

Z + is a counter cation

X and Y 1 are each crosslinkable moieties, and

X and Y 1 covalently crosslink to end-link the monomers.

10. A method for in-situ sequencing of target nucleic acids present in a biological sample comprising the steps of:

a. attaching target nucleic acids present in the sample with a molecule linker or nucleic acid adapter;

b. permeating the sample with a monomer of Formula (A1):

and a monomer of Formula (B1):

to form a hydrogel according to claim 1 by non-radical polymerization and thereby forming a sample-hydrogel complex, wherein the small molecule linker or nucleic acid adaptor is attached both to the target nucleic acids present in the sample and to the hydrogel;

c. digesting proteins present in the sample;

d. expanding the complex to form a first enlarged sample;

e. re-embedding the first enlarged sample in a non-swellable material to form a re-embedded complex;

f. modifying the target nucleic acids or the nucleic acid adaptor to form a target nucleic acids or a nucleic acid adaptor; and

g. sequencing the nucleic acids present in the re-embedded complex;

wherein:

each n is an integer greater than or equal to 1;

each p is an integer greater than or equal to 1;

Z + is a counter cation;

X and Y 1 are each crosslinkable moieties, and

X and Y 1 covalently crosslink to end-link the monomers.

11. A method for enlarging a biological sample for microscopy, the method comprising the steps of:

a) permeating a sample with a first hydrogel, wherein the sample is anchored to the swellable material;

b) swelling the swellable material resulting in a first expanded sample;

c) optionally permeating the first expanded sample with a second hydrogel; and

d) optionally swelling the second hydrogel resulting in a second expanded sample;

wherein the first hydrogel and/or the second hydrogel is the hydrogel of claim 1 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 17, 2021
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 057208/0357 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: GAO, RUIXUAN; GAO, LINYI; YU, CHIH-CHIEH; BOYDEN, EDWARD STUART
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 048894/0643 →
Continuity (2)
Provisional Application 62626920 · Feb 6, 2018
Related Publication 20190256633A1 · Aug 22, 2019